392
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Association of Cytomegalovirus with Idiopathic Chronic Anterior Uveitis with Ocular Hypertension in Korean Patients

, MD & , MD
Pages 192-196 | Received 03 Nov 2012, Accepted 26 Nov 2012, Published online: 12 Mar 2013
 

Abstract

Purpose: To investigate the association between cytomegalovirus and idiopathic chronic recurrent anterior uveitis with ocular hypertension.

Methods: Medical records of 9 consecutive immunocompetent Korean patients with chronic recurrent anterior uveitis and ocular hypertension were retrospectively reviewed. Nested polymerase chain reaction was performed on aqueous humor samples for the herpes family, including cytomegalovirus, varicella zoster virus, herpes simplex virus, and Epstein-Barr virus.

Results: In 7 (77.8%) of 9 patients, aqueous samples were culture-positive for cytomegalovirus (n = 6), Epstein-Barr virus (n = 2), and/or varicella zoster virus (n = 2). Two patients with cytomegalovirus had corneal endotheliitis, and 2 patients with varicella zoster virus had sectoral iris atrophy.

Conclusion: Cytomegalovirus is the most common cause of idiopathic chronic unilateral anterior uveitis with ocular hypertension in immunocompetent Korean patients. The authors suggest that performing polymerase chain reaction on aqueous samples is useful in diagnosing cytomegalovirus in these patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.